Does SOTALOL Cause Interstitial lung disease? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Interstitial lung disease have been filed in association with SOTALOL (Sotalol). This represents 0.5% of all adverse event reports for SOTALOL.
19
Reports of Interstitial lung disease with SOTALOL
0.5%
of all SOTALOL reports
3
Deaths
17
Hospitalizations
How Dangerous Is Interstitial lung disease From SOTALOL?
Of the 19 reports, 3 (15.8%) resulted in death, 17 (89.5%) required hospitalization, and 2 (10.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTALOL. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does SOTALOL Cause?
Drug ineffective (412)
Electrocardiogram qt prolonged (324)
Accidental poisoning (294)
Bradycardia (238)
Atrial fibrillation (219)
Hypotension (208)
Toxicity to various agents (164)
Dyspnoea (152)
Dizziness (149)
Torsade de pointes (145)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which SOTALOL Alternatives Have Lower Interstitial lung disease Risk?
SOTALOL vs SOTATERCEPT
SOTALOL vs SOTATERCEPT-CSRK
SOTALOL vs SOTORASIB
SOTALOL vs SOTROVIMAB
SOTALOL vs SOVALDI